Advantis CEO, Christopher Swartz, is Featured in an Exclusive New Interview at

AUSTIN, Texas, June 13, 2016 (GLOBE NEWSWIRE) --, Inc. (SCV) and ADVANTIS CORPORATION (OTC PINK:ADVT) or (the "Company") announced today that a new audio interview with the Company, is now available. The interview can be heard at

Advantis CEO, Christopher Swartz, called in to, Inc. to discuss what his Company is working on 2016, the various markets they operate in and provide his personal insights to the exciting recent news for Advantis.

Recently Advantis announced that they engaged in a critical letter of intent with Hemp2Health, LLC, a Colorado company, to provide high grade CBD oil extract to Advantis for its product lines. Prior to that news they announced the hiring of Thomas Elgin, MD, as their Chief Medic. Dr. Elgin has worked in emergency medicine for fifteen years, and has extensive experience researching and developing nutraceuticals. CBD based nutraceuticals is the fastest growing sector within the medical marijuana business. Advantis CEO, Christopher Swartz, says that Dr. Elgin will additionally be responsible for testing the efficacy of products Advantis acquires and distributes. Swartz shares the doctor's excitement about the future of CBD technology. "I am passionate about finding effective solutions to cure this chronic pain epidemic," Swartz stated. "Dr. Elgin has been working with me at Sequence Therapy to develop proper exercises, and now at Advantis we will work together to develop effective medicines."

Swartz, stated, “I enjoyed talking about the chronic pain problems we’re addressing for our target markets and our plans for 2016.’s audio presentations are disseminated through the web and to our shareholder base making it a powerful way to get our story to a wider audience.”

About is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about and their services, please visit

About Advantis Corporation

Advantis Corporation (ADVT) develops products and works with developing companies to provide innovative healthcare products, holistic pain management solutions, and enhance the footprint in the evolving legal cannabis business. Advantis acquires ownership in developing companies that work within the nutraceutical and the alternative health care industries; consulting with these organizations to improve their product lines, expand their distribution channels through internal partnership agreements, and heighten brand value.

Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward-looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.

For further information, contact: Media Relations Contact Name: Woo Kim Director Organization: Advantis Corporation Phone: 800-891-0508 Address: 6 Hutton Centre Dr. Santa Ana, CA 92707 E-mail: For Stuart T. Smith 512-267-2430;ADVANTIS CORPORATION